
Regulations and Regulatory Issues
Latest News

Navigating Cannabis Compliance: Expert Tips from Compliance Consultants
Latest Videos
More News

The 1906 cannabis brands and co-founder must pay $400,000 to Colorado and cease operations after failing to disclose health risks of "Midnight Drops."

Our top five cannabis and hemp news this week: OCM fines NY lab, Congress halts rescheduling funding, Texas issues hemp order, NJ supports businesses with $15M in funding, and our latest podcast episode.

Governor Tim Walz signs new cannabis compact with Mille Lacs Band of Ojibwe, a move to regulate the market and support the start of Minnesota adult-use sales.

Test your knowledge of cannabis compliance in 2025. This quiz covers key issues like cross-state expansion and FDA oversight.

New Jersey’s new NJ LEAF program provides up to $1.5M in flexible funding to help cannabis businesses overcome capital access gaps.

New York's cannabis industry has grown to over $2 billion. The OCM's update shows market rebound and new support for equity applicants.

The OCM is taking action against Lexachrom Laboratory for regulatory failures and significant violations, jeopardizing consumer safety and market integrity.

The Texas Cannabis Policy Center and Texas Hemp Business Council both support Governor Abbott’s executive order on hemp regulations.

Our top five cannabis and hemp news this week: Nebraska’s medical cannabis battle, rescheduling debate, Thailand policy shifts, new medical cannabis research, and pricing trends.

Texas Governor Greg Abbott issues an executive order to regulate product sales, requiring ID checks and testing.

New York's legal cannabis sales top $2 billion, with 46 new licenses approved. The state is prioritizing social equity and new education panels.

Thailand's cannabis laws are evolving. A new Prime Minister brings hope for a discussion on legalizing cannabis.

An examination of survey data finds state cannabis laws strongly shape delta-8-THC use, with highest rates in prohibition states.

The Maryland Comptroller reports nearly $18.4 million in Q2 cannabis tax revenue. The Central region, including Baltimore, generated the most income.

Nebraska’s cannabis commission approves restrictive rules, limiting patient access and business licenses.

Here, we bring you our top five recent articles covering federal hemp ban, an interview with Reginald Gaudino, PhD, the reintroduced MORE Act, Delaware cannabis sales and rezoning, and restricting intoxicating hemp-derived cannabinoids.

Delaware's first month of recreational marijuana sales was a success at over $7 million, but the veto of SB 75 shows an ongoing zoning debate.

The organization voiced its support of Texas and other states restricting synthetic hemp cannabinoids, urging science-based regulation to protect consumers, businesses, and public safety.

The MORE Act, a federal cannabis reform bill, has recently been reintroduced to US Congress, with plans to deschedule cannabis and expunge convictions.

Hemp businesses that proactively adopt cGMP certification and rigorous documentation today will be better prepared when federal oversight eventually becomes unavoidable.

A bipartisan group of state and territorial attorneys general have called for Congress to enact the SAFER Banking Act or similar legislation to help with cannabis banking in the industry.

Minnesota DEED grants $3.6 million to help new businesses in the cannabis industry.

Here, we bring you our top five recent articles covering National CBD Day 2025, medical cannabis patients’ workers’ compensation, Trump looking into cannabis rescheduling, research studies on cannabis for sleep, and a clinical trial for CBD and insomnia.

President Trump recently stated interest in considering the reclassification of cannabis with an update on the decision anticipated within the coming weeks. Industry stakeholders, including CST blog author Kim Anzarut, weigh in.

Here, we bring you our top five recent articles covering multiple stories on adult-use cannabis sales in Delaware, the top compliance issues in 2025, and research on how medical cannabis affects healthcare utilization by chronic pain patients.